A Semi-Supervised Learning Algorithm for Predicting Four Types MiRNA-Disease Associations by Mutual Information in a Heterogeneous Network

Increasing evidence suggests that dysregulation of microRNAs (miRNAs) may lead to a variety of diseases. Therefore, identifying disease-related miRNAs is a crucial problem. Currently, many computational approaches have been proposed to predict binary miRNA-disease associations. In this study, in order to predict underlying miRNA-disease association types, a semi-supervised model called the network-based label propagation algorithm is proposed to infer multiple types of miRNA-disease associations (NLPMMDA) by mutual information derived from the heterogeneous network. The NLPMMDA method integrates disease semantic similarity, miRNA functional similarity, and Gaussian interaction profile kernel similarity information of miRNAs and diseases to construct a heterogeneous network. NLPMMDA is a semi-supervised model which does not require verified negative samples. Leave-one-out cross validation (LOOCV) was implemented for four known types of miRNA-disease associations and demonstrated the reliable performance of our method. Moreover, case studies of lung cancer and breast cancer confirmed effective performance of NLPMMDA to predict novel miRNA-disease associations and their association types.

[1]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[2]  B. Reinhart,et al.  The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans , 2000, Nature.

[3]  Bernhard Schölkopf,et al.  Learning with Local and Global Consistency , 2003, NIPS.

[4]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[5]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[7]  Q. Cui,et al.  An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.

[8]  U. Lehmann,et al.  Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancer , 2008, The Journal of pathology.

[9]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[10]  Yadong Wang,et al.  miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..

[11]  Yadong Wang,et al.  Predicting human microRNA-disease associations based on support vector machine , 2010, 2010 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

[12]  Changning Liu,et al.  dbDEMC: a database of differentially expressed miRNAs in human cancers , 2010, BMC Genomics.

[13]  TaeHyun Hwang,et al.  A Heterogeneous Label Propagation Algorithm for Disease Gene Discovery , 2010, SDM.

[14]  Hsien-Da Huang,et al.  miRTar: an integrated system for identifying miRNA-target interactions in human , 2011, BMC Bioinformatics.

[15]  W. Filipowicz,et al.  The widespread regulation of microRNA biogenesis, function and decay , 2010, Nature Reviews Genetics.

[16]  Yadong Wang,et al.  Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.

[17]  Dong Wang,et al.  Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..

[18]  L. Buscail,et al.  The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. , 2010, Clinical chemistry.

[19]  Kevin Struhl,et al.  An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis , 2011, Cell.

[20]  Josh T. Cuperus,et al.  Evolution and Functional Diversification of MIRNA Genes , 2011, Plant Cell.

[21]  Elena Marchiori,et al.  Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..

[22]  S. Lam,et al.  miR-101 DNA Copy Loss is a Prominent Subtype Specific Event in Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[23]  Yong Wang,et al.  Plasma microRNAs as novel biomarkers for early detection of lung cancer. , 2011, International journal of clinical and experimental pathology.

[24]  Yun Xiao,et al.  Prioritizing Candidate Disease miRNAs by Topological Features in the miRNA Target–Dysregulated Network: Case Study of Prostate Cancer , 2011, Molecular Cancer Therapeutics.

[25]  L. Zelek,et al.  Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies , 2012, Breast Cancer Research and Treatment.

[26]  Hailin Chen,et al.  Similarity-based methods for potential human microRNA-disease association prediction , 2013, BMC Medical Genomics.

[27]  Yu Sun,et al.  Serum MicroRNA-155 as a Potential Biomarker to Track Disease in Breast Cancer , 2012, PloS one.

[28]  Diogo M. Camacho,et al.  Wisdom of crowds for robust gene network inference , 2012, Nature Methods.

[29]  Hirotaka Kanzaki,et al.  Novel Direct Targets of miR-19a Identified in Breast Cancer Cells by a Quantitative Proteomic Approach , 2012, PloS one.

[30]  Bingbing Ni,et al.  Learning a Propagable Graph for Semisupervised Learning: Classification and Regression , 2012, IEEE Transactions on Knowledge and Data Engineering.

[31]  S. Tavazoie,et al.  A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells , 2011, Nature.

[32]  M. Bushell,et al.  microRNAs in cancer management. , 2012, The Lancet. Oncology.

[33]  Hao Li,et al.  miR‐137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6 , 2013, FEBS letters.

[34]  Wun-Jae Kim,et al.  Downregulation of cell‐free miR‐198 as a diagnostic biomarker for lung adenocarcinoma‐associated malignant pleural effusion , 2013, International journal of cancer.

[35]  Hsiang-Yuan Yeh,et al.  Inferring drug-disease associations from integration of chemical, genomic and phenotype data using network propagation , 2013, BMC Medical Genomics.

[36]  B. Schmeck,et al.  MicroRNAs in the lung. , 2013, Advances in experimental medicine and biology.

[37]  Xiaoming Liu,et al.  MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3 , 2013, BMC Cancer.

[38]  T. Hijikata,et al.  MicroRNA-1 targets Slug and endows lung cancer A549 cells with epithelial and anti-tumorigenic properties. , 2013, Experimental cell research.

[39]  S. Zhang,et al.  Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. , 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[40]  Yufei Huang,et al.  Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors , 2013, PloS one.

[41]  Changliang Shan,et al.  microRNA‐133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway , 2013, The FEBS journal.

[42]  Jing Zhao,et al.  Breast Cancer: Epidemiology and Etiology , 2014, Cell Biochemistry and Biophysics.

[43]  Hsuan-Yu Chen,et al.  MicroRNA-133a Suppresses Multiple Oncogenic Membrane Receptors and Cell Invasion in Non-Small Cell Lung Carcinoma , 2014, PloS one.

[44]  Xing Chen,et al.  Semi-supervised learning for potential human microRNA-disease associations inference , 2014, Scientific Reports.

[45]  R. Stahel,et al.  Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05). , 2014, Lung cancer.

[46]  Hua Lu,et al.  Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening , 2015, Tumor Biology.

[47]  Jan Gorodkin,et al.  Protein-driven inference of miRNA–disease associations , 2013, Bioinform..

[48]  Hefei Li,et al.  MicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese population , 2014, Medical Oncology.

[49]  E. Olson.  MicroRNAs as Therapeutic Targets and Biomarkers of Cardiovascular Disease , 2014, Science Translational Medicine.

[50]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[51]  Jia Wei,et al.  MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2 , 2015, Tumor Biology.

[52]  K. Pantel,et al.  Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients , 2015, Oncotarget.

[53]  Jie Li,et al.  Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1. , 2015, International journal of biological macromolecules.

[54]  Botao Zhao,et al.  miR-143 inhibits cell proliferation by targeting autophagy-related 2B in non-small cell lung cancer H1299 cells. , 2015, Molecular medicine reports.

[55]  Michelangelo Ceci,et al.  ComiRNet: a web-based system for the analysis of miRNA-gene regulatory networks , 2015, BMC Bioinformatics.

[56]  Qionghai Dai,et al.  RBMMMDA: predicting multiple types of disease-microRNA associations , 2015, Scientific Reports.

[57]  Xiao-Ying Yan,et al.  Prediction of drug-target interaction by label propagation with mutual interaction information derived from heterogeneous network. , 2016, Molecular bioSystems.

[58]  Keqin Li,et al.  Network Consistency Projection for Human miRNA-Disease Associations Inference , 2016, Scientific Reports.

[59]  Michelangelo Ceci,et al.  Semi-Supervised Multi-View Learning for Gene Network Reconstruction , 2015, SEBD.

[60]  Xiangxiang Zeng,et al.  Integrative approaches for predicting microRNA function and prioritizing disease-related microRNA using biological interaction networks , 2016, Briefings Bioinform..

[61]  C. Pasquier,et al.  Prediction of miRNA-disease associations with a vector space model , 2016, Scientific Reports.

[62]  R. D. De Mello,et al.  MicroRNAs in lung cancer , 2017, Oncotarget.

[63]  Y. Xie,et al.  Predicative values of serum microRNA-22 and microRNA-126 levels for non-small cell lung cancer development and metastasis: a case-control study. , 2017, Neoplasma.

[64]  Luqing Zhao,et al.  miR-19b promotes breast cancer metastasis through targeting MYLIP and its related cell adhesion molecules , 2017, Oncotarget.